Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
04/19/2011 | CA2351894C Novel protein, gene encoding the same and method of utilization thereof |
04/19/2011 | CA2320962C Novel mixed amylin activity compounds |
04/19/2011 | CA2320429C Antimicrobial peptides and derived metapeptides |
04/19/2011 | CA2291963C Tumor necrosis factor receptor-derived peptide analogues |
04/19/2011 | CA2282790C Chimeric flavivirus vaccines |
04/19/2011 | CA2220116C Dna encoding glutamate gated chloride channels |
04/19/2011 | CA2195090C Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
04/19/2011 | CA2166117C Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
04/14/2011 | WO2011044504A1 Modulating levels of rna-binding proteins for the treatment of breast cancer |
04/14/2011 | WO2011044365A1 Rothia species glutamine endopeptidases and use thereof |
04/14/2011 | WO2011044254A1 Transgenic plants having enhanced biomass composition |
04/14/2011 | WO2011044186A1 Human single-chain t cell receptors |
04/14/2011 | WO2011044180A1 Methods of production of glycoproteins in mammalian cell cultures using glucocorticoids |
04/14/2011 | WO2011044152A1 Protection against pandemic and seasonal strains of influenza |
04/14/2011 | WO2011043835A1 Polypeptides that bind il-23r |
04/14/2011 | WO2011043834A1 Combinatorial libraries based on c-type lectin domain |
04/14/2011 | WO2011043823A2 Polypeptides that home to atherosclerotic plaque |
04/14/2011 | WO2011043814A2 Fluorescent proteins and uses thereof |
04/14/2011 | WO2011043809A2 Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
04/14/2011 | WO2011043740A1 Peptides for inhibition of myd88-dependent signaling pathways |
04/14/2011 | WO2011042762A2 Insulin like peptides |
04/14/2011 | WO2011042688A1 Pharmaceutical preparation comprising recombinant hcg |
04/14/2011 | WO2011042551A1 Method of generating hcv-derived virus-like particles |
04/14/2011 | WO2011042516A2 Expression system |
04/14/2011 | WO2011042483A1 Antigenic peptides for the detection of chlamydia-related bacteria and tests of diagnosis |
04/14/2011 | WO2011042143A1 Cytochrome p450 from rhizopus oryzae and uses thereof |
04/14/2011 | WO2011042026A1 A cytolytic rtx-toxin from gallibacterium anatis |
04/14/2011 | WO2011041906A1 Surface-coated structures and methods |
04/14/2011 | WO2011041897A1 Compositions and methods for the transport of therapeutic agents |
04/14/2011 | WO2011041847A1 Chaperonin 10 variants |
04/14/2011 | WO2011041839A1 Udp-galactopyranose mutase from haemonchus contortus, and rnai agents that inhibit it |
04/14/2011 | WO2011022667A3 Catalytic domains from lysyl oxidase and loxl2 |
04/14/2011 | WO2011022608A3 Functional expression of yeast nitrate transporter (ynt1) in maize to improve nitrate uptake |
04/14/2011 | WO2011022103A3 Ganglioside epitopes for treating guillain-barre syndrome |
04/14/2011 | WO2011020866A3 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
04/14/2011 | WO2011015634A3 Controlled release formulations of lipocalin muteins |
04/14/2011 | WO2011012254A8 Pichia pastoris as a host for the production of the ribosome-inactivating protein (rip) saporin and saporin fusion chimaeras |
04/14/2011 | WO2010138263A3 Novel aav 's and uses thereof |
04/14/2011 | WO2010124142A3 Cell compositions derived from dedifferentiated reprogrammed cells |
04/14/2011 | WO2010033337A8 Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
04/14/2011 | WO2010001134A3 Insulin fusion polypeptides |
04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
04/14/2011 | US20110088126 Cell signaling genes and related methods |
04/14/2011 | US20110088121 Genes for improving salt tolerance and drought tolerance of plant and the uses thereof |
04/14/2011 | US20110088106 Compositions and methods for mediating cell cycle progression |
04/14/2011 | US20110087007 Cytokine-Like Proteins |
04/14/2011 | US20110087006 DNA Sequence Encoding a Retinoic Acid Regulated Protein |
04/14/2011 | US20110086808 Modified therapeutic agents |
04/14/2011 | US20110086806 Polypeptides that Bind IL-23R |
04/14/2011 | US20110086801 Prevention and reduction of blood loss |
04/14/2011 | US20110086795 Small peptide modulators of potassium channel trafficking |
04/14/2011 | US20110086775 H+-Gated Ion Channel |
04/14/2011 | US20110086768 Transferrin fusion protein libraries |
04/14/2011 | US20110086421 Use of biological photoreceptors as directly light-activated ion channels |
04/14/2011 | US20110086416 Immunotoxin fusion proteins and means for expression thereof |
04/14/2011 | US20110086407 Bacillus licheniformis chromosome |
04/14/2011 | US20110086395 Novel microorganism and its use in lignocellulose detoxification |
04/14/2011 | US20110086391 Expression Vector |
04/14/2011 | US20110086388 Chaperone-assisted protein expression and methods of use |
04/14/2011 | US20110086381 Method for evaluation of function of phagocyte |
04/14/2011 | US20110086367 Pharmaceuticals for influencing the reaction of the human immune system |
04/14/2011 | US20110086345 Isolation and use of ryanodine receptors |
04/14/2011 | US20110086340 Methods, devices, kits and compositions for detecting roundworm |
04/14/2011 | US20110086057 OX40R Binding Agents |
04/14/2011 | US20110086055 Her2 peptides |
04/14/2011 | US20110086054 Yeast strain for the production of proteins with terminal alpha-1,3-linked galactose |
04/14/2011 | US20110086049 Receptor Modulators |
04/14/2011 | US20110086042 Centrosomal Proteins, Nucleic Acids and Method of Use Thereof |
04/14/2011 | US20110086041 Fusion-Intermediate State of HIV-1 gP41 Targeted by Broadly Neutralizing Antibodies |
04/14/2011 | US20110086035 Immunotherapeutic methods and molecules |
04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
04/14/2011 | US20110086019 Polypeptides, antibody variable domains and antagonistsmethods for |
04/14/2011 | US20110086006 HCV NS3-NS4 Protease Resistance Mutants |
04/14/2011 | US20110085989 Novel antimicrobial peptides |
04/14/2011 | US20110085986 Diagnosis and treatment of epithelial cancers using labeled/conjugated progastrin peptides |
04/14/2011 | US20110085939 Node polypeptides for nanostructure assembly |
04/14/2011 | DE112009000148T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation |
04/14/2011 | CA2777222A1 Il-17 family cytokine compositions and uses |
04/14/2011 | CA2777198A1 Use of toll-like receptor and agonist for treating cancer |
04/14/2011 | CA2777162A1 Polypeptides that bind il-23r |
04/14/2011 | CA2777100A1 Surface-coated structures and methods |
04/14/2011 | CA2777096A1 Compositions and methods for the transport of therapeutic agents |
04/14/2011 | CA2777053A1 Human single-chain t cell receptors |
04/14/2011 | CA2777050A1 Methods of production of glycoproteins in mammalian cell cultures using glucocorticoids |
04/14/2011 | CA2776995A1 Insulin like peptides |
04/14/2011 | CA2776969A1 Expression system |
04/14/2011 | CA2776954A1 Combinatorial libraries based on c-type lectin domain |
04/14/2011 | CA2776874A1 Chaperonin 10 variants |
04/14/2011 | CA2776790A1 Pharmaceutical preparation comprising recombinant hcg |
04/14/2011 | CA2776748A1 Use of pedf in an encapsulated cell-based delivery system |
04/14/2011 | CA2776385A1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
04/14/2011 | CA2775573A1 Generation, characterization and uses thereof of anti-her 3 antibodies |
04/14/2011 | CA2775567A1 Transgenic plants having enhanced biomass composition |
04/14/2011 | CA2774941A1 Generation of haploid plants and improved plant breeding |
04/14/2011 | CA2774734A1 A cytolytic rtx-toxin from gallibacterium anatis |
04/13/2011 | EP2309270A1 Antigenic peptides for the detection of chlamydia-related bacteria and tests of diagnosis |
04/13/2011 | EP2309261A1 Methods for evaluating tissue morphogenesis and morphogenic activity |
04/13/2011 | EP2308996A1 Therapeutic and diagnostic applications based on the role of the CXCR-4 and SDF-1 genes in tumourigenesis |
04/13/2011 | EP2308985A2 Plastid genetic engineering via somatic embryogenesis |